Skip to main content

Devices Recalls Guides Research & Treatments Report a problem

MedWatcher

Search Devices Recalls Guides Research & Treatments Report a problem Alerts

Research & Treatments Latest developments

Loading research and source information…

Find medical-device recalls and safety notices, then go to the official record for the action and latest status.

Browse

Search
Devices
Recalls
Guides

Act

Report a problem
Email alerts

About

About MedWatcher
Methodology
Source policy
Disclaimer
Privacy

MedWatcher provides source-backed medical-device safety information. It is not medical advice, a diagnosis tool, emergency service, or adverse-event reporting system. The absence of a recall record is not a statement that a product is safe.

MedWatcher is independent and is not affiliated with, endorsed by, or partnered with any regulator or manufacturer named on this site.

© 2026 MedWatcher.org

Research developments · MedWatcher

Home
Research & Treatments
Developments

Registry updates in our coverage

Source-dated updates from the selected studies. A recent check does not mean the registry record itself changed recently.

Research is not a treatment recommendation. Trial registration, phase and regulatory approval describe different things. Coverage is limited to the listed sources and indications; US approval does not imply approval elsewhere.

ConditionEvent typeClear filters

14 developments · Showing 5–8

Trial updateOct 19, 2026

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin, SGLT2 Inhibitor or Both: registry status update

The registry reports completed. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

Trial updateOct 19, 2026

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes: registry status update

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

Trial updateOct 19, 2026

Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus: registry status update

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

Trial updateOct 19, 2026

A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes: registry status update

The registry reports recruiting. This is trial metadata, not an assessment of treatment benefit.

Original evidence Context and limitations

1 2 3 4